CVS Health upgraded at TD Cowen after insurer unveils 2025 Medicare Advantage plan By Investing.com
Investing.com - Analysts at TD Cowen raised their rating on CVS Health (NYSE:) to "buy" from "hold," citing changes to Medicare Advantage plan benefits for 2025 announced earlier this week.
Along with peers like Humana (NYSE:) and Cigna…